Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Front Plant Sci ; 15: 1384596, 2024.
Article in English | MEDLINE | ID: mdl-38638346

ABSTRACT

Introduction: Hairy vetch (Vicia villosa Roth) is a promising legume cover crop, but its use is limited by high rates of pod dehiscence and seed dormancy. Methods: We used phenotypically contrasting pooled DNA samples (n=24 with 29-74 individuals per sample) from an ongoing cover crop breeding program across four environments (site-year combinations: Maryland 2020, Maryland 2022, Wisconsin 2021, Wisconsin 2022) to find genetic associations and genomic prediction accuracies for pod dehiscence and seed dormancy. We also combined pooled DNA sample genetic association results with the results of a prior genome-wide association study. Results and discussion: Genomic prediction resulted in positive predictive abilities for both traits between environments and with an independent dataset (0.34-0.50), but reduced predictive ability for DNA pools with divergent seed dormancy in the Maryland environments (0.07-0.15). The pooled DNA samples found six significant (false discovery rate q-value<0.01) quantitative trait loci (QTL) for seed dormancy and four significant QTL for pod dehiscence. Unfortunately, the minor alleles of the pod dehiscence QTL increased the rate of pod dehiscence and are not useful for marker-assisted selection. When combined with a prior association study, sixteen seed dormancy QTL and zero pod dehiscence QTL were significant. Combining the association studies did not increase the detection of useful QTL.

2.
Front Plant Sci ; 14: 1282187, 2023.
Article in English | MEDLINE | ID: mdl-37941659

ABSTRACT

Hairy vetch (Vicia villosa Roth), a winter-hardy annual legume, is a promising cover crop. To fully leverage its potential, seed production and field performance of V. villosa must be improved to facilitate producer adoption. Two classic domestication traits, seed dormancy (hard seed) and dehiscence (pod shatter), are selection targets in an ongoing breeding program. This study reports a genome-wide association study of 1,019 V. villosa individuals evaluated at two sites (Knox City, Texas and Corvallis, Oregon) for the proportion of dormant seed, visual pod dehiscence scores, and two dehiscence surrogate measures (force to dehiscence and pod spiraling score). Trait performance varied between sites, but reliability (related to heritability) across sites was strong (dormant seed proportion: 0.68; dehiscence score: 0.61; spiraling score: 0.42; force to dehiscence: 0.41). A major locus controlling seed dormancy was found (q-value: 1.29 × 10-5; chromosome 1: position: 63611165), which can be used by breeding programs to rapidly reduce dormancy in breeding populations. No significant dehiscence score QTL was found, primarily due to the high dehiscence rates in Corvallis, Oregon. Since Oregon is a potentially major V. villosa seed production region, further dehiscence resistance screening is necessary.

3.
J Parasitol ; 109(5): 530-536, 2023 10 01.
Article in English | MEDLINE | ID: mdl-37903502

ABSTRACT

Bovine anaplasmosis, caused by Anaplasma marginale, is widespread in cattle in the southeast United States. The pathogen is biologically transmitted by Dermacentor spp. ticks, and mechanically transmitted by biting flies and via fomites. Despite high reported regional seroprevalence, Dermacentor spp. are rare on cattle in the southeast. To identify other putative An. marginale vectors, and to characterize cattle exposure to other tick-borne pathogens, we collected ticks from Arkansas cattle herds in 2020-2022. Recognizing that deer are important hosts for some of the same tick species that parasitize cattle, we also collected ticks from hunter-killed deer in the fall and winter of 2021. Ticks were screened for bacteria in the family Anaplasmataceae using qPCR. Positive samples were further amplified using a PCR assay targeting the groEL gene, and the resulting amplicons were sequenced for identification. A total of 3,794 ticks were collected, the majority of which were Amblyomma americanum. Amblyomma americanum was the most common species on cattle, and Ixodes scapularis was most common on deer. No ticks were positive for An. marginale, though Anaplasma phagocytophilum was detected in deer-collected I. scapularis, as well as in a single engorged Am. americanum from cattle. Amblyomma americanum from cattle were infected with Ehrlichia ewingii, Ehrilichia chaffeensis, and Panola Mountain Ehrlichia. Cattle in Arkansas are exposed to several ehrlichial pathogens and may also be exposed to An. phagocytophilum. The importance of these pathogens, particularly Panola Mountain Ehrlichia, in causing cattle disease in Arkansas deserves further study, as does the importance of mechanical transmission of An. marginale in bovine anaplasmosis epidemiology.


Subject(s)
Anaplasmosis , Ixodes , Ixodidae , Animals , Cattle , Ehrlichia/genetics , Anaplasma/genetics , Anaplasmosis/epidemiology , Ixodidae/microbiology , Arkansas/epidemiology , Prevalence , Seroepidemiologic Studies , Electron Spin Resonance Spectroscopy , Ixodes/microbiology
4.
J Child Adolesc Trauma ; 15(2): 479-486, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35600518

ABSTRACT

Identifying non-invasive methods for anxiolysis is becoming increasingly important in the pediatric emergency department (ED). Few studies have examined the use of intranasal (IN) ketamine for procedural anxiolysis. We aim to evaluate if IN ketamine provides satisfactory anxiolysis for patients undergoing laceration repair based on anxiety and sedation scoring. We also evaluated the feasibility of using IN ketamine in future trials based on its tolerability and side-effects. A pilot study evaluating IN ketamine in the treatment of procedural anxiety for patients, 2 years and older, weighing 40 kg or less, presenting to the pediatric ED with lacerations. The need for anxiolysis was defined by an elevated modified-Yale Preoperative Anxiety Scale-Short Form (mYPAS-SF) score. Patients received 5 mg/kg of IN ketamine in addition to topical anesthesia, mYPAS-SF scoring before and during the procedure, sedation scoring, adverse events, vital signs, age, weight, laceration size and location, and satisfaction surveys were recorded. Twenty-five patients were enrolled, with mean age of 61 ± 29.2 months and mean weight of 21 ± 6.4 kg. Lacerations were located on the face, extremities, and groin with mean size of 2.1 cm. A decrease in anxiety levels was observed, from median m-YPAS-SF score of 66.7 (62.50-80.2) to 33.3 (27.09-52.00), p < 0.001. Among the patients, 92% (n = 23) were less anxious during the procedure. IN ketamine appears to be safe and well-tolerated with a positive impact on procedural anxiety. A dosage of 5 mg/kg is a reasonable starting point, as 80% of patients had appropriate anxiolysis.

5.
Radiat Prot Dosimetry ; 172(1-3): 121-126, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27412507

ABSTRACT

A new resonator for X-band in vivo EPR nail dosimetry, the dielectric-backed aperture resonator (DAR), is developed based on rectangular TE102 geometry. This novel geometry for surface spectroscopy improves at least a factor of 20 compared to a traditional non-backed aperture resonator. Such an increase in EPR sensitivity is achieved by using a non-resonant dielectric slab, placed on the aperture inside the cavity. The dielectric slab provides an increased magnetic field at the aperture and sample, while minimizing sensitive aperture resonance conditions. This work also introduces a DAR semi-spherical (SS)-TE011 geometry. The SS-TE011 geometry is attractive due to having twice the incident magnetic field at the aperture for a fixed input power. It has been shown that DAR provides sufficient sensitivity to make biologically relevant measurements both in vitro and in vivo Although in vivo tests have shown some effects of physiological motions that suggest the necessity of a more robust finger holder, equivalent dosimetry sensitivity of approximately 1.4 Gy has been demonstrated.


Subject(s)
Biological Assay/instrumentation , Electron Spin Resonance Spectroscopy/instrumentation , Nails/chemistry , Nails/radiation effects , Radiometry/instrumentation , Transducers , Electric Impedance , Equipment Design , Equipment Failure Analysis , Humans , Microwaves , Reproducibility of Results , Sensitivity and Specificity
6.
Int J Mol Sci ; 15(7): 11597-613, 2014 Jun 30.
Article in English | MEDLINE | ID: mdl-24983477

ABSTRACT

Zipper-interacting protein kinase (ZIPK) is a conserved vertebrate-specific regulator of actomyosin contractility in smooth muscle and non-muscle cells. Murine ZIPK has undergone an unusual divergence in sequence and regulation compared to other ZIPK orthologs. In humans, subcellular localization is controlled by phosphorylation of threonines 299 and 300. In contrast, ZIPK subcellular localization in mouse and rat is controlled by interaction with PAR-4. We carried out a comparative biochemical characterization of the regulation of the zebrafish ortholog of ZIPK. Like the human orthologs zebrafish ZIPK undergoes nucleocytoplasmic-shuttling and is abundant in the cytoplasm, unlike the primarily nuclear rat ZIPK. Rat ZIPK, but not human or zebrafish ZIPK, interacts with zebrafish PAR-4. Mutation of the conserved residues required for activation of the mammalian orthologs abrogated activity of the zebrafish ZIPK. In contrast to the human ortholog, mutation of threonine 299 and 300 in the zebrafish ZIPK has no effect on the activity or subcellular localization. Thus, we found that zebrafish ZIPK functions in a manner most similar to the human ZIPK and quite distinct from murine orthologs, yet the regulation of subcellular localization is not conserved.


Subject(s)
Cell Nucleus/metabolism , Death-Associated Protein Kinases/metabolism , Actin Cytoskeleton/metabolism , Active Transport, Cell Nucleus , Amino Acid Sequence , Animals , Death-Associated Protein Kinases/chemistry , Death-Associated Protein Kinases/genetics , HEK293 Cells , HeLa Cells , Humans , Molecular Sequence Data , Species Specificity , Zebrafish
7.
PLoS One ; 8(9): e75766, 2013.
Article in English | MEDLINE | ID: mdl-24040418

ABSTRACT

BACKGROUND: The myosin phosphatase is a highly conserved regulator of actomyosin contractility. Zebrafish has emerged as an ideal model system to study the in vivo role of myosin phosphatase in controlling cell contractility, cell movement and epithelial biology. Most work in zebrafish has focused on the regulatory subunit of the myosin phosphatase called Mypt1. In this work, we examined the critical role of Protein Phosphatase 1, PP1, the catalytic subunit of the myosin phosphatase. METHODOLOGY/PRINCIPAL FINDINGS: We observed that in zebrafish two paralogous genes encoding PP1ß, called ppp1cba and ppp1cbb, are both broadly expressed during early development. Furthermore, we found that both gene products interact with Mypt1 and assemble an active myosin phosphatase complex. In addition, expression of this complex results in dephosphorylation of the myosin regulatory light chain and large scale rearrangements of the actin cytoskeleton. Morpholino knock-down of ppp1cba and ppp1cbb results in severe defects in morphogenetic cell movements during gastrulation through loss of myosin phosphatase function. CONCLUSIONS/SIGNIFICANCE: Our work demonstrates that zebrafish have two genes encoding PP1ß, both of which can interact with Mypt1 and assemble an active myosin phosphatase. In addition, both genes are required for convergence and extension during gastrulation and correct dosage of the protein products is required.


Subject(s)
Catalytic Domain , Myosin-Light-Chain Phosphatase/genetics , Myosin-Light-Chain Phosphatase/metabolism , Protein Phosphatase 1/genetics , Protein Phosphatase 1/metabolism , Sequence Homology, Nucleic Acid , Zebrafish/genetics , Actin Cytoskeleton/metabolism , Amino Acid Sequence , Animals , Cardiac Myosins/metabolism , Gene Expression Regulation, Developmental , HEK293 Cells , HeLa Cells , Humans , Mice , Molecular Sequence Data , Myosin Light Chains/metabolism , Myosin-Light-Chain Phosphatase/chemistry , Phosphorylation , Protein Phosphatase 1/chemistry , Zebrafish/embryology , Zebrafish/metabolism
9.
Curr Opin Pediatr ; 18(2): 184-8, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16601501

ABSTRACT

PURPOSE OF REVIEW: Over-the-counter cough and cold medicines are widely prescribed by general pediatricians in order to relieve cough and other symptoms in the setting of upper respiratory infections. This article will review the pharmacologic components found in over-the-counter cough medicines, the data concerning their use and efficacy in children, the increasing trend of abuse of these medications, and their potential toxicity. RECENT FINDINGS: There is an overall paucity of data evaluating the use of over-the-counter cough medicines in children as well as a lack of evidence for their efficacy. The articles cited will review the efficacy of over-the-counter cough medicines, the emerging trend of abuse of certain preparations such as dextromethorphan, and specific cases of morbidity and even mortality. SUMMARY: According to the limited data that exist, there is not any evidence that over-the-counter cough and cold medicines are effective in children. In otherwise healthy children without chronic complicating factors such as asthma, the symptoms of acute upper respiratory infections are generally mild and self-limited. Pediatricians must weigh the benefits against the potential risks of recommending over-the-counter cough medicines and should be prepared to educate parents about the expected natural course of their child's illness and the likelihood that these medications will be minimally effective in relieving symptoms, if at all.


Subject(s)
Nonprescription Drugs/therapeutic use , Antitussive Agents/adverse effects , Antitussive Agents/therapeutic use , Child , Dextromethorphan/adverse effects , Dextromethorphan/therapeutic use , Drug Overdose , Humans , Infant , Nasal Decongestants/therapeutic use , Nonprescription Drugs/adverse effects , Nonprescription Drugs/poisoning , Phenylpropanolamine/poisoning
SELECTION OF CITATIONS
SEARCH DETAIL
...